Personalized Medicines in Pharmaceutics: Drug Delivery System

Year : 2025 | Volume : 02 | Issue : 01 | Page : 11 22
    By

    R.Shireesh Kiran,

  • Jaggayagari Sarika,

  • Panuganti Pranavi,

  • Kondam Rithikesh,

  • T. Rama Rao,

  1. Associate Professor, CMR College of Pharmacy, Kandlakoya, Medchal, Hyderabad, Telangana, India
  2. Associate Professor, CMR College of Pharmacy, Kandlakoya, Medchal, Hyderabad, Telangana, India
  3. Associate Professor, CMR College of Pharmacy, Kandlakoya, Medchal, Hyderabad, Telangana, India
  4. Student, CMR College of Pharmacy, Kandlakoya, Medchal, Hyderabad, Telangana, India
  5. student, CMR College of Pharmacy, Kandlakoya, Medchal, Hyderabad, Telangana, India

Abstract

Pharmaceutics personalized medicine is a developing area that seeks to customize medical interventions for specific patients. Instead of a one-size-fits-all approach, personalized medicine focuses on developing treatments that consider a person’s unique characteristics, such as their genetic makeup, environment, and lifestyle. This allows for more effective treatment outcomes, as drugs are specifically designed to work best for each patient, reducing side effects and improving therapeutic results. In pharmaceutics, this involves creating customized drug formulations, dosages, and delivery methods that cater to the needs of specific patients. Advances in technologies like genomics, proteomics, and bioinformatics, along with digital health platforms that monitor patient data in real-time, are helping to speed up the progress of personalized medicine. These innovations are changing how drugs are discovered, tested, and administered in clinical settings, leading to more accurate and efficient healthcare solutions. However, there are still challenges to overcome, such as the high cost of developing personalized treatments, complex regulations, and managing large amounts of patient data. It offers the opportunity to create more effective, safer, and patient- specific treatments that can transform the way diseases are treated.

Keywords: Customized Treatment, Bioinformatics, Healthcare innovation, Digital Health Platforms, personalized medicine

[This article belongs to Emerging Trends in Personalized Medicines ]

How to cite this article:
R.Shireesh Kiran, Jaggayagari Sarika, Panuganti Pranavi, Kondam Rithikesh, T. Rama Rao. Personalized Medicines in Pharmaceutics: Drug Delivery System. Emerging Trends in Personalized Medicines. 2024; 02(01):11-22.
How to cite this URL:
R.Shireesh Kiran, Jaggayagari Sarika, Panuganti Pranavi, Kondam Rithikesh, T. Rama Rao. Personalized Medicines in Pharmaceutics: Drug Delivery System. Emerging Trends in Personalized Medicines. 2024; 02(01):11-22. Available from: https://journals.stmjournals.com/etpm/article=2024/view=204275


References

  1. Dimitrovska M. Personalized medicine as trend in pharmaceutical industry. Medis–Int J Med Sci Res. 2024 Mar 7;3(1):31-5.
  2. Jameson JL, Longo DL. Precision medicine—personalized, problematic, and promising. Obstet Gynecol Surv. 2015 Oct 1;70(10):612-4.
  3. Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med. 2010 Jul 22;363(4):301-4.
  4. Trusheim MR, Aitken ML, Berndt ER. Characterizing markets for biopharmaceutical innovations: do biologics differ from small molecules? Forum Health Econ Policy. 2010 Jul 20;13(1).
  5. Lammers LA, Mathijssen RH, van Gelder T, Bijl MJ, de Graan AJ, Seynaeve C, Van Fessem MA, Berns EM, Vulto AG, Van Schaik RH. The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer. Br J Cancer. 2010 Sep;103(6):765-71.
  6. Lee VH. Personalized medicine: transforming drug development and healthcare. Ther Deliv. 2010 Nov 1;1(5):615-9.
  7. Phillips KA, Van Bebber S, Issa AM. Diagnostics and biomarker development: priming the pipeline. Nat Rev Drug Discov. 2006 Jun 1;5(6):463-9.
  8. Vaz VM, Kumar L. 3D printing as a promising tool in personalized medicine. AAPS PharmSciTech. 2021 Jan;22:1-20.
  9. Pandey M, Choudhury H, Fern JL, Kee AT, Kou J, Jing JL, Her HC, Yong HS, Ming HC, Bhattamisra SK, Gorain B. 3D printing for oral drug delivery: a new tool to customize drug delivery. Drug Deliv Transl Res. 2020 Aug;10:986-1001.
  10. Trenfield SJ, Awad A, Goyanes A, Gaisford S, Basit AW. 3D printing pharmaceuticals: drug development to frontline care. Trends Pharmacol Sci. 2018 May 1;39(5):440-51.
  11. Prasad LK, Smyth H. 3D printing technologies for drug delivery: a review. Drug Dev Ind Pharm. 2016 Jul 2;42(7):1019-31.
  12. Water JJ, Bohr A, Boetker J, Aho J, Sandler N, Nielsen HM, Rantanen J. Three-dimensional printing of drug-eluting implants: preparation of an antimicrobial polylactide feedstock material. J Pharm Sci. 2015 Mar 1;104(3):1099-107.
  13. Jain V, Haider N, Jain K. 3D printing in personalized drug delivery. Curr Pharm Des. 2018 Nov 1;24(42):5062-71.
  14. Goole J, Amighi K. 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. Int J Pharm. 2016 Feb 29;499(1-2):376-94.
  15. Al-Metwali B, Mulla H. Personalised dosing of medicines for children. J Pharm Pharmacol. 2017 May;69(5):514-24.
  16. Harvey A, Brand A, Holgate ST, Kristiansen LV, Lehrach H, Palotie A, Prainsack B. The future of technologies for personalised medicine. New Biotechnol. 2012 Sep 15;29(6):625-33.
  17. Palo M, Kogermann K, Laidmae I, Meos A, Preis M, Heinamaki J, Sandler N. Development of oromucosal dosage forms by combining electrospinning and inkjet printing. Mol Pharm. 2017 Mar 6;14(3):808-20.
  18. Ibrahim M, Barnes M, McMillin R, Cook DW, Smith S, Halquist M, Wijesinghe D, Roper TD. 3D printing of metformin HCl PVA tablets by fused deposition modeling: drug loading, tablet design, and dissolution studies. AAPS PharmSciTech. 2019 Jul;20:1-1.
  19. Gioumouxouzis CI, Baklavaridis A, Katsamenis OL, Markopoulou CK, Bouropoulos N, Tzetzis D, Fatouros DG. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery. Eur J Pharm Sci. 2018 Jul 30;120:40-52.
  20. Raijada D, Wac K, Greisen E, Rantanen J, Genina N. Integration of personalized drug delivery systems into digital health. Adv Drug Deliv Rev. 2021 Sep 1;176:113857.
  21. Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J Control Release. 2015 Nov 10;217:308-14.
  22. Vogenberg FR, Barash CI, Pursel M. Personalized medicine: part 1: evolution and development into theranostics. Pharm Ther. 2010 Oct;35(10):560.
  23. Mancinelli L, Cronin M, Sadée W. Pharmacogenomics: the promise of personalized medicine. AAPS PharmSci. 2000 Mar;2:29-41.
  24. Wu BM, Borland SW, Giordano RA, Cima LG, Sachs EM, Cima MJ. Solid free-form fabrication of drug delivery devices. J Control Release. 1996 Jun 1;40(1-2):77-87.
  25. Ursan ID, Chiu L, Pierce A. Three-dimensional drug printing: a structured review. J Am Pharm Assoc. 2013 Mar 1;53(2):136-44.
  26. Ventola CL. Medical applications for 3D printing: current and projected uses. Pharm Ther. 2014 Oct;39(10):704.
  27. Trenfield SJ, Awad A, Goyanes A, Gaisford S, Basit AW. 3D printing pharmaceuticals: drug development to frontline care. Trends Pharmacol Sci. 2018 May 1;39(5):440-51.
  28. Panwar A, Tan LP. Current status of bioinks for micro-extrusion-based 3D bioprinting. Molecules. 2016 May 25;21(6):685.
  29. Marga F, Jakab K, Khatiwala C, Shepherd B, Dorfman S, Hubbard B, Colbert S, Forgacs G. Toward engineering functional organ modules by additive manufacturing. Biofabrication. 2012 Mar 12;4(2):022001.
  30. Goole J, Amighi K. 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. Int J Pharm. 2016 Feb 29;499(1-2):376-94.
  31. Fedorovich NE, Alblas J, de Wijn JR, Hennink WE, Verbout AJ, Dhert WJ. Hydrogels as extracellular matrices for skeletal tissue engineering: state-of-the-art and novel application in organ printing. Tissue Eng. 2007 Aug 1;13(8):1905-25.
  32. Duan B, Hockaday LA, Kang KH, Butcher JT. 3D bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels. J Biomed Mater Res A. 2013 May;101(5):1255-64.
  33. Mehra NK, Jain K, Jain NK. Ethosomes: transdermal delivery. In: Encyclopedia of Biomedical Polymers and Polymeric Biomaterials. 11 Volume Set. CRC Press; 2015 Apr 2. p. 3314-3328.
  34. Ratheesh G, Venugopal JR, Chinappan A, Ezhilarasu H, Sadiq A, Ramakrishna S. 3D fabrication of polymeric scaffolds for regenerative therapy. ACS Biomater Sci Eng. 2017 Jul 10;3(7):1175-94.
  35. Alomari M, Mohamed FH, Basit AW, Gaisford S. Personalised dosing: Printing a dose of one’s own medicine. Int J Pharm. 2015 Oct 30;494(2):568-77.
Regular Issue Subscription Review Article
Volume 02
Issue 01
Received 09/11/2024
Accepted 02/12/2024
Published 11/12/2024
Publication Time 32 Days
554

Login


My IP

PlumX Metrics